SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-007490
Filing Date
2024-01-29
Accepted
2024-01-29 09:15:29
Documents
16
Period of Report
2024-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244305d1_8k.htm   iXBRL 8-K 25460
2 EXHIBIT 99.1 tm244305d1_ex99-1.htm EX-99.1 19206
6 GRAPHIC tm244305d1_ex99-1img001.jpg GRAPHIC 11954
  Complete submission text file 0001104659-24-007490.txt   242038

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA epix-20240125.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE epix-20240125_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epix-20240125_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT tm244305d1_8k_htm.xml XML 3697
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37410 | Film No.: 24570660
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)